Medicine Man Technologies Inc (SHWZ)

[damAcon1]

Listening to these MSOs use cost compression and competition as an excuse for falling revenue and/or EBITDA. As if their limited licensed, siloed, markets were going to last for an infinite amount of time.

Boris Jordan Q4 and EoY conference call was questioned multiple times about EBITDA:

"But one needs to understand, those markets, California, Colorado, Oregon, Michigan, they're never going to have the 30-plus percent EBITDA margin, at least not in the foreseeable future. I think the best we can do in those marketplaces is going to be somewhere between 20% and 25%."


Justin Dye: <<<hold my beer>>>
Q2-21: Adjusted EBITDA is $10.0 Million, 32.6% of Revenue
Q3-21: Adjusted EBITDA is $8.8 Million, 27.6% of Revenue